Anixa Biosciences, Inc. Gains 27.46%
Fri, Sep 16, 2022 at 07:21 PM
Anixa Biosciences, Inc. (ANIX:NASDAQ) soared at $5.71, representing a gain of 27.5%. On Fri, Sep 16, 2022, ANIX:NASDAQ touched a New 2-Week High of $5.71. The stock appeared on our News Catalysts scanner on Mon, Sep 12, 2022 at 08:57 AM in the 'BIOTECH' category. From Fri, Sep 02, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days
About Anixa Biosciences, Inc. (ANIX:NASDAQ)
ITUS Corp is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers.
Top 10 Gainers:
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 53.03%
- Applied Optoelectronics, Inc. (AAOI:NASDAQ), 50.4%
- iBio, Inc. (IBIO:NYSEMKT), 49.84%
- Armata Pharmaceuticals Inc. (ARMP:NYSEMKT), 31.15%
- Axcella Health Inc. (AXLA:NASDAQ), 29.57%
- Anixa Biosciences, Inc. (ANIX:NASDAQ), 27.46%
- Lannett Company, Inc. (LCI:NYSE), 25.1%
- Integrated Media Technology Limited (IMTE:NASDAQ), 21.53%
- Innate Pharma S.A. (IPHA:NASDAQ), 20.87%
- TMC the metals company Inc. (TMC:NASDAQ), 20.19%